3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
2
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Thyroid Neoplasms
5
Thyroid Cancer, Papillary
2
Carcinoma, Non-Small-Cell Lung
2
Thyroid Diseases
1
Thyroid Carcinoma, Anaplastic
1
Sexual Dysfunction, Physiological
1
Neoplasms
1
Gastrointestinal Neoplasms
1
Eunuchism
1
Erectile Dysfunction
1
Carcinoma, Medullary
1
Cachexia-Anorexia Syndrome
1
Breast Neoplasms
1
Advanced Thyroid Cancer Patients Who Received Target Therapy
1
Adenocarcinoma, Follicular
1
Interventions
Sorafenib
3
cabozantinib
2
Sodium
2
Radiofrequency Ablation
2
Metformin
2
Data Collection
2
vandetanib
1
temsirolimus
1
selpercatinib
1
pembrolizumab
1
lenvatinib
1
apatinib
1
acetaminophen, codeine drug combination
1
Watchful Waiting
1
Tramadol
1
Thyroxine
1
Thyroidectomy
1
Thyroid (USP)
1
Technetium Tc 99m Sestamibi
1
Panobinostat
1
Observation
1
Negative-Pressure Wound Therapy
1
NAc-Sar-Gly-Val-(d-allo-Ile)-Thr-Nva-Ile-Arg-ProNEt
1
Lysine Acetyltransferase 5
1
Iodine-131
1
Interviews as Topic
1
Indocyanine Green
1
Hyperspectral Imaging
1
Focus Groups
1
Fluorescein
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Thyroid Diseases
×
selpercatinib
×
Clear all
NCT07543887
2026-04-22
EECRTKI
University of Pisa
Completed
15 enrolled